Determinants of poor 6-min walking distance in patients with COPD: The ECLIPSE cohort

Respiratory Medicine

Volumn 104, Issue 6, 2010, Pages 849-857

  Spruit, Martijn A ^a   Watkins, Michael L ^b   Edwards, Lisa D ^b   Vestbo, Jørgen ^c,d   Calverley, Peter M A ^e   Pinto Plata, Victor ^f   Celli, Bartolome R ^f   Tal Singer, Ruth ^b   Wouters, Emiel F M ^a,g  

^a Program Development Centre   (Netherlands)

^b GLAXOSMITHKLINE   (United States)

^c HVIDOVRE HOSPITAL   (Denmark)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^f ST ELIZABETH'S MEDICAL CENTER   (United States)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

6 min Walking test; 6MWD; Chronic obstructive pulmonary disease, COPD; Determinants; Functional performance; Multicentre

Indexed keywords

OXYGEN;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DYSPNEA; EMPHYSEMA; EXERCISE TOLERANCE; FEMALE; HUMAN; IMPEDANCE; MAJOR CLINICAL STUDY; MALE; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; SPIROMETRY; SYMPTOM; WALKING; CLINICAL TRIAL; EXERCISE TEST; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; RADIOGRAPHY;

ADULT; AGED; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SPIROMETRY; WALKING;

EID: 77952288073     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.12.007     Document Type: Article

References (39)

1. Palange P., Ward S.A., Carlsen K.H., Casaburi R., Gallagher C.G., Gosselink R., et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J 29 1 (2007 Jan) 185-209
2. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 1 (2002 Jul 1) 111-117
3. Troosters T., Vilaro J., Rabinovich R., Casas A., Barbera J.A., Rodriguez-Roisin R., et al. Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease. Eur Respir J 20 3 (2002 Sep) 564-569
4. Cote C.G., Casanova C., Marin J.M., Lopez M.V., Pinto-Plata V., de Oca M.M., et al. Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J 31 3 (2008 Mar) 571-578
5. Pitta F., Troosters T., Spruit M.A., Probst V.S., Decramer M., and Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 9 (2005 May 1) 972-977
6. Spruit M.A., Gosselink R., Troosters T., De Paepe K., and Decramer M. Resistance versus endurance training in patients with COPD and peripheral muscle weakness. Eur Respir J 19 6 (2002 Jun) 1072-1078
7. Puhan M.A., Mador M.J., Held U., Goldstein R., Guyatt G.H., and Schunemann H.J. Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J 32 3 (2008 Sep) 637-643
8. Lacasse Y., Goldstein R., Lasserson T.J., and Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2006) (4):CD003793
9. Garrod R., Marshall J., Barley E., and Jones P.W. Predictors of success and failure in pulmonary rehabilitation. Eur Respir J 27 4 (2006 Apr) 788-794
10. Probst V.S., Troosters T., Coosemans I., Spruit M.A., Pitta Fde O., Decramer M., et al. Mechanisms of improvement in exercise capacity using a rollator in patients with COPD. Chest 126 4 (2004 Oct) 1102-1107
11. Fishman A., Martinez F., Naunheim K., Piantadosi S., Wise R., Ries A., et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 348 21 (2003 May 22) 2059-2073
12. Cazzola M., MacNee W., Martinez F.J., Rabe K.F., Franciosi L.G., Barnes P.J., et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 31 2 (2008 Feb) 416-469
13. Pinto-Plata V.M., Cote C., Cabral H., Taylor J., and Celli B.R. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 23 1 (2004 Jan) 28-33
14. Cote C.G., Pinto-Plata V., Kasprzyk K., Dordelly L.J., and Celli B.R. The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest 132 6 (2007 Dec) 1778-1785
15. Casanova C., Cote C.G., Marin J.M., de Torres J.P., Aguirre-Jaime A., Mendez R., et al. The 6-min walking distance: long-term follow up in patients with COPD. Eur Respir J 29 3 (2007 Mar) 535-540
16. Carter R., Holiday D.B., Nwasuruba C., Stocks J., Grothues C., and Tiep B. 6-minute walk work for assessment of functional capacity in patients with COPD. Chest 123 5 (2003 May) 1408-1415
17. Ischaki E., Papatheodorou G., Gaki E., Papa I., Koulouris N., and Loukides S. Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest 132 1 (2007 Jul) 164-169
18. Huijsmans R.J., de Haan A., ten Hacken N.N., Straver R.V., and van't Hul A.J. The clinical utility of the GOLD classification of COPD disease severity in pulmonary rehabilitation. Respir Med 102 1 (2008 Jan) 162-171
19. Lee Y.K., Oh Y.M., Lee J.H., Kim E.K., Kim N., Seo J.B., et al. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 186 3 (2008 May-Jun) 157-165
20. Carr S.J., Goldstein R.S., and Brooks D. Acute exacerbations of COPD in subjects completing pulmonary rehabilitation. Chest 132 1 (2007 Jul) 127-134
21. Spruit M.A., Pennings H.J., Janssen P.P., Does J.D., Scroyen S., Akkermans M.A., et al. Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade. Respir Med 101 12 (2007 Dec) 2454-2463
22. Eiser N., West C., Evans S., Jeffers A., and Quirk F. Effects of psychotherapy in moderately severe COPD: a pilot study. Eur Respir J 10 7 (1997 Jul) 1581-1584
23. de Torres J.P., Casanova C., Hernandez C., Abreu J., Montejo de Garcini A., Aguirre-Jaime A., et al. Gender associated differences in determinants of quality of life in patients with COPD: a case series study. Health Qual Life Outcomes 4 (2006) 72
24. Vestbo J., Anderson W., Coxson H.O., Crim C., Dawber F., Edwards L., et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J 31 4 (2008 Apr) 869-873
25. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 6 (2007 Sep 15) 532-555
26. Quanjer P.H., Tammeling G.J., Cotes J.E., Fabbri L.M., Matthys H., Pedersen O.F., et al. Symbols, abbreviations and units. Working Party Standardization of lung function tests, European Community for Steel and Coal. Eur Respir J Suppl 16 (1993 Mar) 85-100
27. Steiner M.C., Barton R.L., Singh S.J., and Morgan M.D. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 19 4 (2002 Apr) 626-631
28. Ferris B.G. Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis 118 6 Pt 2 (1978 Dec) 1-120
29. Radloff L.S. A self-report depression scale for research in the general population. J Appl Psychol Meas 1 3 (1977) 385-401
30. Jones P.W., Quirk F.H., Baveystock C.M., and Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 145 6 (1992 Jun) 1321-1327
31. Bestall J.C., Paul E.A., Garrod R., Garnham R., Jones P.W., and Wedzicha J.A. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54 7 (1999 Jul) 581-586
32. Celli B.R., Cote C.G., Marin J.M., Casanova C., Montes de Oca M., Mendez R.A., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 10 (2004 Mar 4) 1005-1012
33. DeLong E.R., DeLong D.M., and Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44 3 (1988 Sep) 837-845
34. Marin J.M., Carrizo S.J., Gascon M., Sanchez A., Gallego B., and Celli B.R. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 6 (2001 May) 1395-1399
35. Wegner R.E., Jorres R.A., Kirsten D.K., and Magnussen H. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 7 4 (1994 Apr) 725-729
36. Kessler R., Faller M., Fourgaut G., Mennecier B., and Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159 1 (1999 Jan) 158-164
37. Pitta F., Troosters T., Probst V.S., Spruit M.A., Decramer M., and Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest 129 3 (2006 Mar) 536-544
38. Savale L., Chaouat A., Bastuji-Garin S., Marcos E., Boyer L., Maitre B., et al. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009 Jan 29)
39. Broekhuizen R., Wouters E.F., Creutzberg E.C., and Schols A.M. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61 1 (2006 Jan) 17-22